ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Novara — A Smarter Way to Access Global Markets
Markets/EquitiesArticle

Centrus Energy Stock Hits 52-Week Low at $141.61

Shares of Centrus Energy slid 21% in a week and are down 39% over the year, while analysts remain split on valuation.

PA
Priya Anand · Equities & Earnings Desk · 16 Sept 2026 · 10:50 · 1 min read
Share
Centrus Energy Stock Hits 52-Week Low at $141.61

Centrus Energy Corp. shares hit a 52-week low of $141.61, continuing a steep slide that has erased roughly two-fifths of the stock’s value over the past year. The stock dropped 21% over the past week alone.

The company, which trades under the ticker LEU, maintains a market capitalization of $2.92 billion. It recently announced an underwritten public offering of Class A common stock, pre-funded warrants, and common warrants. Its Compensation, Nominating & Governance Committee also approved performance-based restricted stock units for executives tied to milestones at its production facility in Piketon, Ohio.

Analyst sentiment remains mixed. Jefferies initiated coverage with a Hold rating and a price target of $169. Stifel kept its Buy rating but lowered its price target to $216 from $246, citing solid second-quarter 2026 results and significant backlog growth at the company. UBS maintained a Neutral rating and revised its price target upward to $185 from $170, updating adjusted EBITDA estimates to reflect higher gross margins.

An InvestingPro analysis suggested the stock was overvalued relative to its calculated fair value, though no specific fair-value figure was disclosed in the report.

This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Share this story
PA
Written by
Priya Anand
Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

More from Priya Anand →
ADVERTISEMENT
ADVERTISEMENT